☰

John R. Richert

Affiliations: 
Georgetown University Medical Center, Washington, DC, United States 
Area:
Neuroscience Biology, Molecular Biology
Google:
"John Richert"
Mean distance: 21373.2
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Eric M. Hernandez grad student 2004 Georgetown University Medical Center
Kelly M. Moran grad student 2004 Georgetown University Medical Center
Leonard N. Chen grad student 2005 Georgetown University Medical Center
Azik D. Schwechter grad student 2006 Georgetown University Medical Center

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Stuart WH, Cohan S, Richert JR, et al. (2004) Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis. Neurology. 63: S19-27
Moran KM, Crusio RH, Chan CH, et al. (2004) Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis. Gene. 341: 235-47
Koehler NK, Yang CY, Varady J, et al. (2004) Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein. Journal of Medicinal Chemistry. 47: 4989-97
Hernandez EM, Chan CH, Xu B, et al. (2004) Role of an internal ribosome entry site in the translational control of the human transcription factor Sp3. International Journal of Oncology. 24: 719-24
Hernandez EM, Johnson A, Notario V, et al. (2002) AUA as a translation initiation site in vitro for the human transcription factor Sp3. Journal of Biochemistry and Molecular Biology. 35: 273-82
Grekova MC, Salerno K, Mikkilineni R, et al. (2002) Sp3 expression in immune cells: a quantitative study. Laboratory Investigation; a Journal of Technical Methods and Pathology. 82: 1131-8
Simon JH, Lull J, Jacobs LD, et al. (2000) A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon β-1a Neurology. 55: 185-192
Grekova MC, Scherer SW, Trabb J, et al. (2000) Localization of the human SP3 gene to chromosome 7p14-p15.2. The lack of expression in multiple sclerosis does not reflect abnormal gene organization. Journal of Neuroimmunology. 106: 214-9
Rudick RA, Cookfair DL, Simonian NA, et al. (1999) Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Journal of Neuroimmunology. 93: 8-14
Herndon R, Jacobs L, Coats M, et al. (1999) Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon Beta-1a (Avonex) Treatment in Multiple Sclerosis International Journal of Ms Care. 1: 3-11
See more...